SHORT GLENMARK PHARMA FOR A TARGET OF RS 628. DEMAND ZONE AT 626. STOCK HAS BROKE THE SUPPORT OF 635.
Supply and DemandSupport and Resistance

Aussi sur:

Clause de non-responsabilité